25
Views
2
CrossRef citations to date
0
Altmetric
Article

Increased expression of TCR Vβ5.1 and 8 in mucosal T‐cell Lines cultured from patients with Crohn disease

, , , &
Pages 238-245 | Received 09 Sep 2003, Accepted 10 Nov 2003, Published online: 08 Jul 2009

References

  • Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S–11S.
  • van den BR, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000;40:336–45.
  • Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, etal. Selective Expansion of T Cells expressing T-cell receptor variable regions Vbeta2 and Vbeta8 in Kawasaki disease. PNAS 1992;89: 4066.
  • Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. The Crohn’s disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity 2001;15: 149–58.
  • Agnholt J, Kaltoft K, Jakobsen NO, Dahlerup JF. T-cell vaccination in Crohn’s disease: principles and presentation of the first two cases. Cytokines Cell Mol Ther 2002;7:117–23.
  • Lugering N, Kucharzik T, Fisahn M, Domschke W, Stoll R. Crohn’s disease (CD) patients suffering from peripheral arthritis or ankylosing spondylitis reveal restricted T cell receptor V beta regions in different temporal phases of disease. Clin Exp Immunol 1996;105:278–84.
  • May E, Marker-Hermann E, Wittig BM, Zeitz M, Meyer zum Buschenfelde KH, Duchmann R. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 2000;119:1745–55.
  • Aisenberg J, Ebert E, Mayer L. T-cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology 1993;105:1421–30.
  • Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn’s disease. J Clin Invest 1990;85:1770–6.
  • Baca-Estrada ME, Wong DK, Croitoru K. Cytotoxic activity of V beta 8+ T cells in Crohn’s disease: the role of bacterial superantigens. Clin Exp Immunol 1995;99: 398–403.
  • Gulwani-Akolkar B, Akolkar PN, Minassian A, McKinley M, Fisher S, Silver J. CD4+ cell oligoclonality in Crohn’s disease: evidence for an antigen-specific response. Hum Immunol 1996; 48:114–24.
  • Ogawa H, Ito H, Takeda A, Kanazawa S, Yamamoto M, Nakamura H, et al. Universal skew of T cell receptor (TCR) V beta usage for Crohn’s disease (CrD). Biochem Biophys Res Commun 1997;240:545–51.
  • Prindiville TP, Cantrell MC, Matsumoto T, Brown WR, Ansari AA, Kotzin BL, et al. Analysis of function, specificity and T cell receptor expression of cloned mucosal t cell lines in Crohn’s disease. J Autoimmunity 1996;9:193–204.
  • Nakajima A, Kodama T, Yazaki Y, Takazoe M, Saito N, Suzuki R, et al. Specific clonal T cell accumulation in intestinal lesions of Crohn’s disease. J Immunol 1996;157:5683–8.
  • Watanabe M, Hayashi A, Hosoda Y, Ohara M, Iwao Y, Ishii H, et al. Preferential activation of CD4 + Vbeta 5.2/5.3 + intestinal intraepithelial lymphocytes in the inflamed lesions of Crohn’s disease. Clin Immunol Immunopathol 1996;78:130–9.
  • Saubermann LJ, Probert CSJ, Christ AD, Chott A, Turner JR, Stevens AC, et al. Evidence of T cell receptor beta -chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol Gastrointest Liver Physiol 1999;276:G613–G621.
  • Bennet JD, Brown WR, Kotzin BL. Regional variation in the lamina propria T cell receptor Vbeta repertoire in normal human colon. Clin Immunol 1999;90:38–46.
  • May E, Lambert C, Holtmeier W, Hennemann A, Zeitz M, Duchmann R. Regional variation of the alpha/beta T cell repertoire in the colon of healthy individuals and patients with Crohn’s disease. Hum Immunol 2002;63:467–80.
  • Agnholt J, Kaltoft K. In situ activated intestinal T cells expanded in vitro—without addition of antigen—produce IFN-gamma and IL-10 and preserve their function during growth. Exp Clin Immunogenet 2001;18:213–25.
  • Agnholt J, Kaltoft K. Infliximab downregulates interferongamma production in activated gut T-lymphocytes from patients with Crohn’s disease. Cytokine 2001;15:212–22.
  • Van Kerckhove C, Russell GJ, Deusch K, Reich K, Bhan AK, DerSimonian H, et al. Oligoclonality of human intestinal intraepithelial T cells. J Exp Med 1992;175:57–63.
  • Nielsen MB, Odum N, Gerwien J, Svejgaard A, Bendtzen K, Bregentholt S, et al. Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines. Tissue Antigens 1998;52:530–8.
  • Lionetti P, Spencer J, Breese EJ, Murch SH, Taylor J, MacDonald TT. Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol 1993;23:664–8.
  • Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin ‘superantigens’ with human T cells. Proc Natl Acad Sci USA 1989;86:8941–5.
  • Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000;30:3247–55.
  • Chiba M, Hoshina S, Kono M, Tobita M, Fukushima T, Iizuka M, et al. Staphylococcus aureus in inflammatory bowel disease. Scand J Gastroenterol 2001;36:615–20.
  • Sutton CL, Kim J, Yamane A, Dalwadi H, Wei B, Landers C, et al. Identification of a novel bacterial sequence associated with Crohn’s disease. Gastroenterology 2000;119:23–31.
  • Wei B, Huang T, Dalwadi H, Sutton CL, Bruckner D, Braun J. Pseudomonas fluorescens encodes the Crohn’s disease-associated I2 sequence and T-cell superantigen. Infect Immun 2002; 70:6567–75.
  • Arenz M, Herzog-Hauff S, Meyer zum Buschenfelde KH, Lohr HF. Antigen-independent in vitro expansion of T cells does not affect the T cell receptor V beta repertoire. J Mol Med 1997;75: 678–86.
  • Jason J, Inge KL. The effects of mitogens, IL-2 and anti-CD3 antibody on the T-cell receptor V beta repertoire. Scand J Immunol 1996;43:652–61.
  • Muraro PA, Jacobsen M, Necker A, Nagle JW, Gaber R, Sommer N, et al. Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 2000;246:131–43.
  • Izeradjene K, Revillard JP. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment. Transplantation 2001;71:118–25.
  • Bakker JM, Kavelaars A, Kamphuis PJGH, Zijlstra J, van Bel F, Heijnen CJ. Neonatal dexamethasone treatment induces long- lasting changes in T-cell receptor V[beta] repertoire in rats. J Neuroimmunology 2001;112:47–54.
  • Blumberg RS, Yockey CE, Gross GG, Ebert EC, Balk SP. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J Immunol 1993;150:5144–53.
  • Farstad IN, Halstensen TS, Lien B, Kilshaw PJ, Lazarovits AI, Brandtzaeg P, et al. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 1996;89:227–37.
  • Hall BL, Finn OJ. PCR-based analysis of the T-cell receptor V beta multigene family: experimental parameters affecting its validity. Biotechniques 1992;13:248–57.
  • Rebai N, Pantaleo G, Demarest JF, Ciurli C, Soudeyns H, Adelsberger JW, et al. Analysis of the T-cell receptor beta-chain variable-region Vbeta repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific Vbeta segments in CD4+ T cells of the viruspositive twins. Proc Natl Acad Sci USA 1994;91:1529–33.
  • Wong FS, Hibberd ML, Wen L, Millward BA, Demaine AG. The human T cell receptor V beta repertoire of normal peripheral blood lymphocytes before and after mitogen stimulation. Clin Exp Immunol 1993;92:361–6.
  • Van Der AA, Hellings N, Medaer R, Gelin G, Palmers Y, Raus J, et al. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. Clin Exp Immunol 2003;131:155–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.